Abstract
Acquired hemophilia A (AHA) is a rare bleeding disorder caused by functional insufficiency of coagulation factor VIII (FVIII). Autoantibodies targeting FVIII may neutralize its procoagulant effect, thereby causing severe bleeding. Such inhibitory autoantibodies have been detected in autoimmune diseases, pregnancy, infections, or malignant diseases. Older age and certain drugs are known co‐risk factors.1 To our knowledge, only two reported cases document AHA diagnosed 8 and 20 days after influenza vaccination.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
